These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 454928)

  • 41. Solubilization and characterization of [3H]spiroperidol binding sites from subcellular fractions of the calf striatum.
    Clement-Cormier YC; Kendrick PE
    Biochem Pharmacol; 1980 Mar; 29(6):897-903. PubMed ID: 7387707
    [No Abstract]   [Full Text] [Related]  

  • 42. Ovine prolactin administration modifies [3H]spiperone binding to striatal membranes of rabbits.
    Eva C; Blengio M; Ferretti C; Muccioli G; Portaleone P
    Brain Res; 1982 Nov; 251(2):388-90. PubMed ID: 7139336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of stereospecific [3H]spiroperidol binding sites in mammalian lymphocytes.
    Le Fur G; Phan T; Uzan A
    Life Sci; 1980 Apr; 26(14):1139-48. PubMed ID: 7392792
    [No Abstract]   [Full Text] [Related]  

  • 44. The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro.
    Howard JL; Large BT; Wedley S; Pullar IA
    Life Sci; 1978 Aug; 23(6):599-603. PubMed ID: 29198
    [No Abstract]   [Full Text] [Related]  

  • 45. 3H-Spiroperidol binding to striatal membranes of mutant Han-Wistar rats which exhibit spastic paresis.
    Golombiowska-Nikitin K; Sontag KH; Osborne NN
    Experientia; 1981 May; 37(5):490-1. PubMed ID: 7250319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ontogenetic development of the striatal [3H]spiperone binding: regulation by sodium and guanine nucleotide in rats.
    Nomura Y; Oki K; Segawa T
    J Neurochem; 1982 Apr; 38(4):902-8. PubMed ID: 6174692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the effects of substituted benzamides and standard neuroleptics on the binding of 3H-spiroperidol in the rat pituitary and striatum with in vivo effects on rat prolactin secretion.
    Meltzer HY; So R; Miller RJ; Fang VS
    Life Sci; 1979 Aug; 25(7):573-83. PubMed ID: 41148
    [No Abstract]   [Full Text] [Related]  

  • 48. Chronic treatment with metoclopramide induces behavioral supersensitivity to apomorphine and enhances specific binding of 3H-spiroperidol to rat striata.
    Lautin A; Wazer D; Stanley M; Rotorsen J; Gershon S
    Life Sci; 1980 Jul; 27(4):305-16. PubMed ID: 7412477
    [No Abstract]   [Full Text] [Related]  

  • 49. Specific in vivo binding of neuroleptic drugs in rat brain.
    Laduron P; Leysen J
    Biochem Pharmacol; 1977 May; 26(10):1003-7. PubMed ID: 861040
    [No Abstract]   [Full Text] [Related]  

  • 50. The effects of exercise training on [3H]-spiperone binding in rat striatum.
    Gilliam PE; Spirduso WW; Martin TP; Walters TJ; Wilcox RE; Farrar RP
    Pharmacol Biochem Behav; 1984 Jun; 20(6):863-7. PubMed ID: 6087370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biochemical properties of spiperone binding to rat brain membranes.
    Sundermann RH; Wooten GF
    Pharmacology; 1980; 21(4):295-305. PubMed ID: 6106952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.
    Leysen JE; Gommeren W; Laduron PM
    Biochem Pharmacol; 1978 Feb; 27(3):307-16. PubMed ID: 23126
    [No Abstract]   [Full Text] [Related]  

  • 53. Demonstration of neuroleptic receptor sites in mouse brain by autoradiography.
    Höllt V; Schubert P
    Brain Res; 1978 Jul; 151(1):149-53. PubMed ID: 679000
    [No Abstract]   [Full Text] [Related]  

  • 54. In vivo stereospecific [3H]spiperone binding in rat brain: characteristics, regional distribution, kinetics and pharmacological properties.
    Barone D; Luzzani F; Assandri A; Galliani G; Mennini T; Garattini S
    Eur J Pharmacol; 1985 Oct; 116(1-2):63-74. PubMed ID: 4054217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regional study of 3H-spiperone binding and the dopamine-sensitive adenylate cyclase in rat brain.
    Quik M; Iversen LL
    Eur J Pharmacol; 1979 Jul; 56(4):323-30. PubMed ID: 477728
    [No Abstract]   [Full Text] [Related]  

  • 56. Decreased [3H]serotonin and [3H]spiperone binding consequent to lipid peroxidation in rat cortical membranes.
    Muakkassah-Kelly SF; Andresen JW; Shih JC; Hochstein P
    Biochem Biophys Res Commun; 1982 Feb; 104(3):1003-10. PubMed ID: 7073721
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of morphine, beta-endorphin and leu-enkephalin on 3H-spiroperidol binding to bovine pituitary membranes.
    Meltzer HY; So R
    Life Sci; 1979 Aug; 25(6):531-5. PubMed ID: 491848
    [No Abstract]   [Full Text] [Related]  

  • 58. Examination of des-tyrosine1-gamma-endorphin activity at oH-spiroperidol binding sites in rat brain.
    Pedigo NW; Ling NC; Reisine TD; Yamamura HI
    Life Sci; 1979 Apr; 24(18):1645-9. PubMed ID: 481099
    [No Abstract]   [Full Text] [Related]  

  • 59. A comparison between centrifugation and filtration as a means to separate bound and unbound ligand during 3[H]-spiroperidol binding.
    Csernansky CA; Csernansky JG; Hollister LE
    J Pharmacol Methods; 1985 Jun; 13(3):187-91. PubMed ID: 3999754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 3H-spiroperidol binding sites in lymphocytes of patients and individuals at risk of Huntington's disease.
    de Yebenes JG; Bazán E; Muradas V; Reiriz J; Mena MA
    Neurology; 1985 Jul; 35(7):1084. PubMed ID: 3159973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.